期刊
ONCOLOGY
卷 94, 期 5, 页码 324-328出版社
KARGER
DOI: 10.1159/000486680
关键词
Combinations in oncology; Dendrimers; Camptothecin; Cisplatin; Paclitaxel; Doxorubicin; MG132
类别
资金
- FCT - Fundacao para a Ciencia e a Tecnologia [PEst-OE/QUI/UI0674/2013]
- ARDITI - Centro de Quimica da Madeira - CQM+ (Madeira 14-20) [M1420-01-0145-FEDER-000005]
- CNRS (France)
The metallo-phosphorus dendrimer 1G3-Cu (generation 3 dendrimer bearing 48 conjugated copper(II) on its surface) has antiproliferative activity related to its capacity to activate Bax translocation. In the present study, we evaluate the activity of an association of 1G3-Cu with 5 cytotoxic agents used in chemotherapy having different modes of action. Data show no additive effect with camptothecin and cisplatin, additivity with paclitaxel and MG132, and synergy with doxorubicin. Results suggest that the multivalent Cu-conjugated dendrimer 1G3-Cu ( activator of Bax translocation) plays an important role in boosting the clinical impact of Bax accumulation stimulated by the proteasome inhibitor MG132, antimitotic taxanes, and the topo II inhibitor doxorubicin. (C) 2018 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据